Molecular genetics of epithelial ovarian neoplasms: Correlations to phenotype and biological behaviour;Molekulargenetik der epithelialen ovarialneoplasien: Korrelationen zum Phanotyp und biologischen Verhalten

Pathologe

Volumn 19, Issue 2, 1998, Pages 95-103

  Diebold, J ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

LMP tumors; Molecular genetics; Molecular pathology; Morphology; Ovarian carcinomas

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

CHROMOSOME ABERRATION; CYTOGENETICS; ENDOMETRIOID CARCINOMA; FEMALE; GENE MUTATION; GENE OVEREXPRESSION; GYNECOLOGIC CANCER; HUMAN; HUMAN TISSUE; OVARY CANCER; PHENOTYPE; REVIEW; TUMOR SUPPRESSOR GENE;

CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 17; DNA MUTATIONAL ANALYSIS; EPITHELIUM; FEMALE; HUMANS; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; OVARY; PHENOTYPE; TUMOR MARKERS, BIOLOGICAL;

EID: 0031905396     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002920050260     Document Type: Review

References (72)

1. Bosari S, Viale G, Radaelli U, Bossi P, Bonoldi E, Coggi G (1993) p53 accumulation in ovarian carcinomas and its prognostic implications. Hum Pathol 24:1175-1179
2. Bryan EJ, Watson RH, Davis M, Hitchcock A, Foulkes WD, Campbell IG (1996) Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q. Cancer Res 56:719-721
3. Buller RE, Skilling JS, Kaliszewski S, Niemann T, Anderson B (1995) Absence of significant germ line p53 mutations in ovarian cancer patients. Gynecol Oncol 58 368-374
4. Burks RT, Sherman ME, Kurman RJ (1996) Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol 20:1319-1330
5. Chenevix-Trench G, Leary J, Kerr J, Michel J, Kefford R, Hurst T, Parsons PG, Friedlander M, Khoo SK (1992) Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus. Oncogene 7:1059-1065
6. Cheng P, Schmutte C, Cofer KF, Felix JC, Yu MC, Dubeau L (1997) Alterations in DNA methylation are early, but not initial, events in ovarian tumorigenesis. Br J Cancer 75:396-402
7. Cheng PC, Gosewehr JA, Kim TM, Velicescu M, Wan M, Zheng J, Felix JC, Cofer KF, Luo P, Biela BH, Godorov G, Dubeau L (1996) Potential role of the inactivated X chromosome in ovarian epithelial tumor development. J Natl Cancer Inst 88:510-518
8. Counter CM, Hirte HW, Bacchetti S, Harley CB (1994) Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 91:2900-2904
9. Devlin J, Elder PA, Gabra H, Steel CM, Knowles MA (1996) High frequency of chromosome 9 deletion in ovarian cancer: evidence for three tumour-suppressor loci. Br J Cancer 73:420-423
10. Diebold J, Baretton G, Felchner M, Meier W, Dopfer K, Schmidt M, Löhrs U (1996) Bcl2 expression, p53 accumulation and apoptosis in ovarian carcinomas. Am J Clin Pathol 105:341-349
11. Diebold J, Deisenhofer I, Baretton GB, Blasenbreu S, Suchy B, Schneiderbanger K, Meier W, Haas CJ, Lohrs U (1996) Interphase cytogenetic analysis of serous ovarian tumors of low malignant potential: comparison with serous cystadenomas and invasive serous carcinomas. Lab Invest 75:473-485
12. Diebold J, Schmid S, Haas CJ, Baretton GB, Lohrs U (1997) Analyse von Mikrosatelliten-polymorphismen in serösen Tumoren von niedrig malignem Potential des Ovars. Verh Dtsch Ges Pathol 81:548
13. Diebold J, Siegert S, Baretton GB, Suchy B, Meier W, Haas CJ, Löhrs U (1997) Interphase cytogenetic analysis of mucinous ovarian neoplasms. Lab Invest 76:661-669
14. Diebold J, Suchy B, Barretton GB, Blasenbreu S, Meier W, Schmidt M, Rabes H, Löhrs U (1996) DNA ploidy and MYC DNA amplification in ovarian carcinomas. Correlation with p53 and bcl-2 expression, proliferative activity and prognosis. Virchows Arch 429:221-227
15. Dietl J, Marzusch K (1993) Ovarian surface epithelium and human ovarian cancer. Gynecol Obstet Invest 35:129-135
16. Dodson MK, Hartmann LC, Cliby WA, DeLacey KA, Keeney GL, Ritland SR, Su JQ, Podratz KC, Jenkins RB (1993) Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas. Cancer Res 53:4456-4460
17. Eccles DM, Russell SE, Haites NE, Atkinson R, Bell DW, Gruber L, Hickey I, Kelly K, Kitchener H, Leonard R et al. (1992) Early loss of heterozygosity on 17q in ovarian cancer. The Abe Ovarian Cancer Genetics Group. Oncogene 7:2069-2072
18. Fajac A, Benard J, Lhomme C, Rey A, Duvillald P, Rochard F, Bernaudin JF, Riou G (1995) c-erbB2 gene amplification and protein expression in ovarian epithelial tumors: evaluation of their respective prognostic significance by multivariate analysis. Int J Cancer 64:146-151
19. Foulkes WD, Campbell IG, Stamp GW, Trowsdale J (1993) Loss of heterozygosity and amplification on chromosome 11 q in human ovarian cancer. Br J Cancer 67:268-273
20. Foulkes WD, Ragoussis J, Stamp GW, Allan GJ, Trowsdale J (1993) Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma. Br J Cancer 67:551-559
21. Fujita M, Enomoto T, Yoshino K, Nomura T, Buzard GS, Inoue M, Okudaira Y (1995) Microsatellite instability and alterations in the hMSH2 gene in human ovarian cancer. Int J Cancer 64:361-366
22. Compel A, Sabourin JC, Martin A, Yaneva H, Audoum J, Decroix Y, Poitout P (1994) Bcl-2 expression in normal endometrium during the menstrual cycle. Am J Pathol 144:1195-1202
23. Haldane JS, Hird V, Hughes CM, Gullick WJ (1990) c-erbB-2 oncogene expression in ovarian cancer. J Pathol 162:231-237
24. Henriksen R, Strang P, Wilander E, Backstrom T, Tribukait B, Oberg K (1994) p53 expression in epithelial ovarian neoplasms: relationship to clinical and pathological parameters, Ki-67 expression and flow cytometry. Gynecol Oncol 53:301-306
25. Henriksen R, Wilander E, Oberg K (1995) Expression and prognostic significance of Bcl-2 in ovarian tumours. Br J Cancer 72 1324-1329
26. Ichikawa Y, Nishida M, Suzuki H, Yoshida S, Tsunoda H, Kubo T, Uchida K, Miwa M (1994) Mutation of K-ras protooncogene is associated with histological subtypes in human mucinous ovarian tumors. Cancer Res 54:33-35
27. Iwabuchi H, Sakamoto M, Sakunaga H, Ma YY, Carcangiu ML, Pinkel D, Yang-Feng TL, Gray JW (1995) Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res 55:6172-6180
28. Jacobs IJ, Smith SA, Wiseman RW, Futreal PA, Harrington T, Osborne RJ, Leech V, Molyneux A, Berchuk A, Ponder BA et al. (1993) A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus. Cancer Res 53:1218-1221
29. Jenkins RB, Bartelt D Jr, Stalboerger P, Persons D, Dahl RJ, Podratz K, Keeney G, Hartmann L (1993) Cytogenetic studies of epithelial ovarian carcinoma. Cancer Genet Cytogenet 71:76-86
30. Kappes S, Milde-Langosch K, Kressin P, Passlack B, Dockhorn-Dworniczak B, Rohlke P, Loning T (1995) p53 mutations in ovarian tumors, detected by temperature-gradient gel electrophoresis, direct sequencing and immunohistochemistry. Int J Cancer 64:52-59
31. Kim JW, Cho YH, Kwon DJ, Kim TE, Park TC, Lee JM, Namkoong SE (1995) Aberrations of the p53 tumor suppressor gene in human epithelial ovarian carcinoma. Gynecol Oncol 57:199-204
32. King BL, Carcangiu ML, Carter D, Kiechle M, Pfisterer J, Pfleiderer A, Kacinski BM (1995) Microsatellite instability in ovarian neoplasms. Br J Cancer 72:376-382
33. Kleihues P, Schäuble B, zur Hausen A, Esteve J, Ohgaki H (1997) Tumors associated with p53 germline mutations. A synopsis of 91 families. Am J Pathol 150:1-13
34. Kobayashi K, Sagae S, Kudo R, Saito H, Koi S, Nakamura Y (1995) Microsatellite instability in endometrial carcinomas: frequent replication errors in tumors of early onset and/or of poorly differentiated type. Genes Chromosomes Cancer 14:128-132
35. Kohler MF, Marks JW, Wiseman RW, Jacobs IJ, Davidoff AM, Clarke-Pearson DL, Soper JT, Bast RC Jr, Berchuck A (1993) Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer. J Natl Cancer Inst 85:1513-1519
36. Kupryjanczyk J, Thor AD, Beauchamp R, Merritt V, Edgerton SM, Bell DA, Yandell DW (1993) p53 gene mutations and protein accumulation in human ovarian cancer. Proc Natl Acad Sci USA 90:4961-4965
37. Kurman RJ, Trimble CL (1993) The behavior of serous tumors of low malignant potential: are they ever malignant? Int J Gynecol Pathol 12:120-127
38. Lee JH, Kavanagh JJ, Wildrick DM, Wharton JT, Blick M (1990) Frequent loss of heterozygosity on chromosomes 6q, 11 and 17 in human ovarian carcinomas. Cancer Res 50:2724-2728
39. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88:323-331
40. Mazars R, Pujol P, Maudelonde T, Jeanteur P, Theillet C (1991) p53 mutations in ovarian cancer: a late event? Oncogene 6:1685-1690
41. Merajver SD, Pham TM, Caduff RF, Chen M, Poy EL, Cooney KA, Weber BL, Collins FS, Johnston C, Frank TS (1995) Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nat Genet 9:439-443
42. Milner BJ, Allan LA, Eccles DM, Kitchener HC, Leonard RC, Kelly KF, Parkin DE, Haites NE (1993) p53 mutation is a common genetic event in ovarian carcinoma. Cancer Res 53:2128-2132
43. Mok SC, Bell DA, Knapp RC, Fishbaugh PM, Welch WR, Muto MG, Berkowitz RS, Tsao SW (1993) Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res 53:1489-1492
44. Okamoto A, Sameshima Y, Yokoyama S, Terashima Y, Sugimura T, Terada M, Yokota J (1991) Frequent allelic losses and mutations of the p53 gene in human ovarian cancer. Cancer Res 51:5171-5176
45. Orphanos V, McGown G, Hey Y, Thorncroft M, Santibanez-Koref M, Russell SE, Hickey I, Atkinson RJ, Boyle JM (1995) Allelic imbalance of chromosome 6q in ovarian tumours. Br J Cancer 71:666-669
46. Osborne RJ, Leech V (1994) Polymerase chain reaction allelotyping of human ovarian cancer. Br J Cancer 69:429-438
47. Pejovic T (1995) Genetic changes in ovarian cancer. Ann Med 27:73-78
48. Pejovic T, Heim S, Mandahl N, Baldetorp B, Elmfors B, Floderus UM, Furgyik S, Helm G, Himmelmann A, Willen H (1992) Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chromosom Cancer 4:58-68
49. Persons DL, Hartmann LC, Herath JF, Borell TJ, Cliby WA, Keeney GL, Jenkins RB (1993) Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas. Am J Pathol 142:733-741
50. Pieretti M, Cavalieri C, Conway PS, Gallion HH, Powell DE, Turker MS (1995) Genetic alterations distinguish different types of ovarian tumors. Int J Cancer 64:434-440
51. Renninson J, Baker BW, McGown AT, Murphy D, Norton JD, Fox BW, Crowther D (1994) Immunohistochemical detection of mutant p53 protein in epithelial ovarian cancer using polyctonal antibody CMI: correlation with histopathology and clinical features. Br J Cancer 69:609-612
52. Rubin SC, Benjamin I, Behbakht K, Takahashi H, Morgan MA, LiVolsi VA, Berchuck A, Muto MG, Garber JE, Weber BL, Lynch HT, Boyd J (1996) Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med 335:1413-1416
53. Rubin SC, Finstad CL, Federici MG, Scheiner L, Lloyd KO, Hoskins WJ (1994) Prevalence and significance of HER-2/neu expression in early epithelial ovarian cancer. Cancer 73:1456-1459
54. Russell P (1994) Surface epithelial-stromal tumors of the ovary. In: Kurman RJ (ed) Blaustein's pathology of the female genital tract. Springer, Berlin Heidelberg New York, pp 705-782
55. Saito S, Saito H, Koi S, Sagae S, Kudo R, Saito J, Noda K, Nakamura Y (1992) Fine-scale deletion mapping of the distal long arm of chromosome 6 in 70 human ovarian cancers. Cancer Res 52:5815-5817
56. Sato T, Saito H, Morita R, Koi S, Lee JH, Nakamura Y (1991) Allelotype of human ovarian cancer. Cancer Res 51:5118-5122
57. Schlegel J, Stumm G, Scherthan H, Bocker T, Zirngibl H, Ruschoff J, Hofstädter F (1995) Comparative genomic in situ hybridization of colon carcinomas with replication error. Cancer Res 55:6002-6005
58. Seidman JD, Kurman RJ (1996) Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. Am J Surg Pathol 20:1331-1345
59. Shenson DL, Gallion HH, Powell DE, Pieretti M (1995) Loss of heterozygosity and genomic instability in synchronous endometrioid tumors of the ovary and endometrium. Cancer 76:650-657
60. Singleton TP, Perrone T, Oakley G, Niehans GA, Carson L, Cha SS, Strickler JG (1994) Activation of c-erbB-2 and prognosis in ovarian carcinoma. Comparison with histologic type, grade, and stage. Cancer 73:1460-1466
61. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A et al. (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712
62. Stratton JF, Gayther SA, Russell P, Dearden J, Gore M, Blake P, Easton D, Ponder BA (1997) Contribution of BRCA1 mutations to ovarian cancer. N Engl J Med 336:1125-1130
63. Takahashi H, Behbakht K, McGovern PE, Chiu HC, Couch FJ, Weber BL, Friedman LS, King MC, Furusato M, LiVolsi VA (1995) Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res 55:2998-3002
64. Tanaka K, Boice CR, Testa JR (1989) Chromosome aberrations in nine patients with ovarian cancer. Cancer Genet Cytogenet 43:1-14
65. Tangir J, Loughridge NS, Berkowitz RS, Muto MG, Bell DA, Welch WR, Mok SC (1996) Frequent microsatellite instability in epithelial borderline ovarian tumors. Cancer Res 56:2501-2505
66. Tavassoli M, Ruhrberg C, Beaumont V, Reynolds K, Kirkham N, Collins WP, Farzaneh F (1993) Whole chromosome 17 loss in ovarian cancer. Genes Chromosom Cancer 8:195-198
67. Teneriello MG, Ebina M, Linnoila RI, Henry M, Nash JD, Park RC, Birrer MJ (1993) p53 and Kiras gene mutations in epithelial ovarian neoplasms. Cancer Res 53:3103-3108
68. Thompson FH, Emerson J, Alberts D, Liu Y, Guan XY, Burgess A, Fox S, Taetle R, Weinstein R, Makar R et al. (1994) Clonal chromosome abnormalities in 54 cases of ovarian carcinoma. Cancer Genet Cytogenet 73:33-45
69. Thompson FH, Liu Y, Emerson J, Weinstein R, Makar R, Trent JM, Taetle R, Alberts DS (1994) Simple numeric abnormalities as primary karyotype changes in ovarian carcinoma. Genes Chromosom Cancer 10:262-266
70. Wan M, Li WZ, Duggan BD, Felix JC, Zhao Y, Dubeau L (1997) Telomerase activity in benign and malignant epithelial ovarian tumors. J Natl Cancer Inst 89:437-441
71. Wertheim I, Tangir J, Muto MG, Welch WR, Berkowitz RS, Chen WY, Mok SC (1996) Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumors. Oncogene 12:2147-2153
72. Yang-Feng TL, Han H, Chen KC, Li SB, Claus EB, Carcangiu ML, Chambers SK, Chambers JT, Schwartz PE (1993) Allelic loss in ovarian cancer. Int J Cancer 54:546-551